Pittsburgh, Pennsylvania, United States
Franchise lead for for Oncology and Inflammation Biosimilar products containing Mvasi, Kanjinti, Riabni, Neulasta, Amjevita, and Wezlana
-Supported critical transformation programs including Merck Accelerate -Provided day-to-day process and programmatic support for other enterprise projects -Partnered with Enterprise Strategy Office teammates, divisional / functional colleagues, and external colleagues on project work -Assisted in developing updates for Merck's leaders, Accelerate Management, and other stakeholders
-Ensured high-quality, on-time, and accurate deliverables to all stakeholders for all monthly closes, quarterly forecasts, tallies, budgets, and LROP -Prepared summaries of MMD's financials to senior management including the VP and Controller MMD, MMD President, and Manufacturing Leadership Team -Modeled MMD's annual five-year LROP by capturing various inputs received from the business -Serve as subject matter expert in manufacturing accounting concepts, such as deferrals, standard cost productivity, and standard revision -Prepared ad hoc analyses and summaries of MMD's financials -Supported the Integrated P&L process -Supported special divisional projects
-Collaborated in teams to perform audits and reviews for American, British, and Japanese clients -Interfaced with cross-functional middle to C-level management to gain an understanding of procedures and judgment -Analyzed financial data to ensure the completeness and accuracy of representations for private equity, broker-dealer, real estate, consumer product, and healthcare technology clients